Home › Uveal Melanoma › Michigan
Uveal Melanoma clinical trials in Michigan
3 studies for Uveal Melanoma are looking for participants at sites in Michigan.
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
- Cancer Hematology Centers Western Michigan, Grand Rapids
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07804186Neoadjuvant Darovasertib in Primary Uveal Melanoma
- W Kellogg Eye Center, Ann Arbor
- The Cancer and Hematology Centers of West Michigan (CHCWM), Grand Rapids
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT07015190A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- University of Michigan Hospitals, Ann Arbor
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2025 · NCT06805825From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.